Form 10-Q ImmunoCellular Therapeut For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
ImmunoCellular Therapeutics (IMUC) Tops Q3 EPS by 2c
November 10, 2015 4:33 PM ESTImmunoCellular Therapeutics (NYSE: IMUC) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
... More